Literature DB >> 20636287

Abnormal mechanisms of antisaccade generation in schizophrenia patients and unaffected biological relatives of schizophrenia patients.

Seung Suk Kang1, Daphne P Dionisio, Scott R Sponheim.   

Abstract

Although errant saccadic eye movements may mark genetic factors in schizophrenia, little is known about abnormal brain activity that precedes saccades in individuals with genetic liability for schizophrenia. We investigated electrophysiological activity preceding prosaccades and antisaccades in schizophrenia patients, first-degree biological relatives of schizophrenia patients, and control subjects. Prior to antisaccades, patients had reduced potentials over lateral prefrontal cortex. Smaller potentials were associated with worse antisaccade performance. Relatives also exhibited reduced pre-saccadic potentials over lateral frontal cortex but additionally had reduced potentials over parietal cortex. Both patients and relatives tended toward increased activity over orbital frontal cortex prior to saccades. Results are consistent with lateral prefrontal dysfunction marking genetic liability for schizophrenia and underlying deficient saccadic control. Journal compilation
© 2010 Society for Psychophysiological Research. No claim to original US government works.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20636287      PMCID: PMC2994980          DOI: 10.1111/j.1469-8986.2010.01074.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  71 in total

1.  The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria.

Authors:  A Raine
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

2.  A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system.

Authors:  P McGuffin; A Farmer; I Harvey
Journal:  Arch Gen Psychiatry       Date:  1991-08

3.  Task-switching in schizophrenia: active switching costs and passive carry-over effects in an antisaccade paradigm.

Authors:  Cathleen Greenzang; Dara S Manoach; Donald C Goff; Jason J S Barton
Journal:  Exp Brain Res       Date:  2007-05-08       Impact factor: 1.972

4.  Voluntary control of saccadic eye movement in patients with frontal cortical lesions and parkinsonian patients in comparison with that in schizophrenics.

Authors:  J Fukushima; K Fukushima; K Miyasaka; I Yamashita
Journal:  Biol Psychiatry       Date:  1994-07-01       Impact factor: 13.382

5.  Eye movement disorders after frontal eye field lesions in humans.

Authors:  S Rivaud; R M Müri; B Gaymard; A I Vermersch; C Pierrot-Deseilligny
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

6.  SCID II interviews and the SCID Screen questionnaire as diagnostic tools for personality disorders in DSM-III-R.

Authors:  L Ekselius; E Lindström; L von Knorring; O Bodlund; G Kullgren
Journal:  Acta Psychiatr Scand       Date:  1994-08       Impact factor: 6.392

7.  Reduced microstructural integrity of the white matter underlying anterior cingulate cortex is associated with increased saccadic latency in schizophrenia.

Authors:  Dara S Manoach; G Avinash Ketwaroo; Frida E Polli; Katharine N Thakkar; Jason J S Barton; Donald C Goff; Bruce Fischl; Mark Vangel; David S Tuch
Journal:  Neuroimage       Date:  2007-05-21       Impact factor: 6.556

8.  Saccadic system functioning among schizophrenia patients and their first-degree biological relatives.

Authors:  B A Clementz; J E McDowell; S Zisook
Journal:  J Abnorm Psychol       Date:  1994-05

9.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

Authors:  J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich
Journal:  Arch Gen Psychiatry       Date:  1994-11

10.  Schizophrenia patients show impaired response switching in saccade tasks.

Authors:  Cosima Franke; Benedikt Reuter; Lisa Schulz; Norbert Kathmann
Journal:  Biol Psychol       Date:  2007-07-03       Impact factor: 3.251

View more
  7 in total

Review 1.  Behavioural and computational varieties of response inhibition in eye movements.

Authors:  Vassilis Cutsuridis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-04-19       Impact factor: 6.237

2.  Personality traits across the psychosis spectrum: A Hierarchical Taxonomy of Psychopathology conceptualization of clinical symptomatology.

Authors:  Julia M Longenecker; Robert F Krueger; Scott R Sponheim
Journal:  Personal Ment Health       Date:  2019-07-15

Review 3.  Electrophysiological Endophenotypes for Schizophrenia.

Authors:  Emily M Owens; Peter Bachman; David C Glahn; Carrie E Bearden
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

4.  Impaired top-down modulation of saccadic latencies in patients with schizophrenia but not in first-degree relatives.

Authors:  Simon Schwab; Miriam Jost; Andreas Altorfer
Journal:  Front Behav Neurosci       Date:  2015-02-24       Impact factor: 3.558

5.  Activated PI3Kδ syndrome, an immunodeficiency disorder, leads to sensorimotor deficits recapitulated in a murine model.

Authors:  Ines Serra; Olivia R Manusama; Fabian M P Kaiser; Izi Izumi Floriano; Lucas Wahl; Christian van der Zalm; Hanna IJspeert; P Martin van Hagen; Nico J M van Beveren; Sandra M Arend; Klaus Okkenhaug; Johan J M Pel; Virgil A S H Dalm; Aleksandra Badura
Journal:  Brain Behav Immun Health       Date:  2021-10-19

6.  Eye-head coordination abnormalities in schizophrenia.

Authors:  Simon Schwab; Othmar Würmle; Nadja Razavi; René M Müri; Andreas Altorfer
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

7.  Evaluating the Specificity of Cognitive Control Deficits in Schizophrenia Using Antisaccades, Functional Magnetic Resonance Imaging, and Healthy Individuals With Poor Cognitive Control.

Authors:  Amanda L Rodrigue; David J Schaeffer; Jordan E Pierce; Brett A Clementz; Jennifer E McDowell
Journal:  Front Psychiatry       Date:  2018-04-11       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.